Transplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation ConditioningIsoantigensLymphocyte Culture Test, MixedHematologic NeoplasmsTransplantation ChimeraTissue DonorsT-LymphocytesGraft vs Tumor EffectGraft SurvivalOrgan TransplantationTissue and Organ ProcurementTransplantation, IsogeneicWhole-Body IrradiationStem Cell TransplantationGraft vs Leukemia EffectLeukemiaSkin TransplantationHistocompatibility TestingHistocompatibilityGraft RejectionMice, Inbred C57BLGraft vs Host ReactionTransplantation ImmunologyLymphocyte ActivationSpleenMice, Inbred BALB CTransplantation, AutologousBusulfanRecurrenceTreatment OutcomeCytotoxicity, ImmunologicImmunosuppressive AgentsMultiple Organ FailureImmunosuppressionLymphocyte DepletionRemission InductionDendritic CellsLeukemia, Myeloid, AcuteTime FactorsRadiation ChimeraMyeloablative AgonistsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocyte TransfusionPeripheral Blood Stem Cell TransplantationOrgan SpecificityImmune ToleranceOrgan SizeVidarabineBlood Transfusion, AutologousLymphocytesOrgan of CortiAcute DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensTransplantation ToleranceMice, Inbred StrainsRetrospective StudiesAnemia, AplasticChimerismCytomegalovirus InfectionsMice, Inbred C3HT-Lymphocytes, CytotoxicHistocompatibility AntigensMyelodysplastic SyndromesSurvival AnalysisCells, CulturedBlood TransfusionH-2 AntigensCD4-Positive T-LymphocytesThymus GlandCytotoxicity Tests, ImmunologicKiller Cells, NaturalSurvival RateAllograftsCD8-Positive T-LymphocytesImmunotherapy, AdoptiveBone Marrow CellsChimeraAntigens, CDCyclosporineHematologic DiseasesAntilymphocyte SerumCyclophosphamideT-Lymphocytes, RegulatoryMinor Histocompatibility AntigensImmunophenotypingAntibodies, MonoclonalCombined Modality TherapyFlow CytometryGraft Enhancement, ImmunologicHepatic Veno-Occlusive DiseaseMajor Histocompatibility ComplexImmunity, CellularBone MarrowLeukemia, MyeloidSiblings